Workflow
湖北国企改革板块10月24日跌1.68%,广济药业领跌,主力资金净流出11.54亿元
Sou Hu Cai Jing·2025-10-24 08:59

Core Insights - The Hubei state-owned enterprise reform sector experienced a decline of 1.68% on October 24, with Guangji Pharmaceutical leading the drop at -10.05% [1][2] - The Shanghai Composite Index closed at 3950.31, up 0.71%, while the Shenzhen Component Index closed at 13289.18, up 2.02% [1] Stock Performance Summary - Tianfeng Securities (601162) closed at 5.25, up 0.96%, with a trading volume of 2.7 million shares and a turnover of 1.409 billion yuan [1] - Guangji Pharmaceutical (000952) closed at 6.98, down 10.05%, with a trading volume of 683,800 shares [2] - Wuhan Holdings (600168) closed at 5.57, down 9.58%, with a trading volume of 1.3015 million shares [2] - Hubei Energy (000883) closed at 4.74, down 1.04%, with a trading volume of 482,000 shares and a turnover of 229 million yuan [1][2] Capital Flow Analysis - The Hubei state-owned enterprise reform sector saw a net outflow of 1.154 billion yuan from institutional investors, while retail investors had a net inflow of 794 million yuan [2][3] - Tianfeng Securities had a net inflow of 96.285 million yuan from institutional investors, while retail investors experienced a net outflow of 30.078 million yuan [3] - Hubei Energy had a net inflow of 44.389 million yuan from institutional investors, with retail investors seeing a net outflow of 35.716 million yuan [3]